Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus causes a pneumonia syndrome, with specific and already well-described symptoms, and fatal outcome in a subset of patients. The lungs are… Continue Reading

Tim J von Oertzen, Ronan McGinty, Martin Holtkamp, Reetta Kalviainen, Stephan Ruegg, Eugen Trinka, Guido Rubboli 3rd April 2020 Physicians of all specialties worldwide are challenged by the new SARS-CoV-2 virus causing corona virus disease 2019 (COVID-19). The virus is… Continue Reading

During the Covid-19 pandemic, most European countries have imposed personal restrictions on their populations in order to inhibit viral transmission and spread of infection. The hardest restriction concerns the imposition not to leave home unless to go to the supermarket,… Continue Reading

Recently released guidance on stroke management during the current COVID-19 pandemic emphasises carefully managed triage, importance of appropriate personal protective equipment, and crisis resource management.

by Ettore Beghi & Daniel Berekzcki An unexpected outbreak due to the infection by the coronavirus, Covid-19, which started in China at the end of 2019, is rapidly expanding and is now officially assigned pandemic status by the WHO. After… Continue Reading

Prof. Claudio Bassetti, President of the EAN and Prof. Mohamed Al-Shehab, President of the PAUNS are pleased to announce that: EAN signed a Memorandum of Understanding with PAUNS – Pan Arab Union of Neurological Societies joining forces to promote optimal… Continue Reading

The World Muslcle Society has recently published its position and advice on the COVID-19 and people with neuromuscular disorders.

Prof. Claudio Bassetti, President of the EAN and Prof. Wim Oyen, President of the EANM are pleased to announce that: EAN signed a Memorandum of Understanding with EANM – European Association of Nuclear Medicine joining forces to promote optimal cooperation… Continue Reading

EMA communication: Highlights of patient, consumer, and healthcare professional activities in 2019 EMA is happy to share the Highlights of patient, consumer, and healthcare professional activities in 2019 with you. EAN is a member of the above Committee. Prof. Marianne… Continue Reading

Aiming to improve the conditions of people living with neurological disorders, the European Federation of Neurological Associations (EFNA) will focus on three advocacy themes for 2020-2025: Access to treatment, services and support Stigma, isolation and discrimination and Patient empowerment, engagement… Continue Reading

No change to the conditions of use of the direct oral anticoagulants Eliquis (apixaban), Pradaxa (dabigatran etexilate) and Xarelto (rivaroxaban) is needed following a review of the results of a European study of real-world data for these medicines. The study,… Continue Reading

EU and national authorities are continuing their work to prevent and manage the presence of nitrosamine impurities in EU medicines. Nitrosamines are classified as probable human carcinogens (substances that could cause cancer) based on animal studies. They are present in… Continue Reading

During this time of uncertainty regarding COVID-19, the 30th Alzheimer Europe Conference #30AEC is still planned to take place in Bucharest from 20-22 October 2020. Our call for abstracts is open, as are registrations, with Early Bird fees available until… Continue Reading